Patent intelligence · US
US 10350296
Chewable gelatin formulations
Chewable gelatin formulations
Patent details — US 10350296
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 16, 2019
- Expiration
- Jul 11, 2039
- Applicant
- Aspire Pharmaceuticals
- Claims
- 8
- CPC classes
- A61K, A61K47/42, A61K9/0056
Quick answer
US 10350296 (Chewable gelatin formulations) is held by Aspire Pharmaceuticals. Status: granted. Granted Jul 16, 2019. Expires Jul 11, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Aspire Pharmaceuticals
- Grant date
- Expiration
- Claims
- 8
- CPC classes
- A61K, A61K47/42, A61K9/0056
Frequently asked questions
What is US patent 10350296?
US 10350296 (Chewable gelatin formulations) is held by Aspire Pharmaceuticals. Status: granted. Granted Jul 16, 2019. Expires Jul 11, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10350296?
Aspire Pharmaceuticals is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1 pharmaceutical patents for this assignee.
When does US 10350296 expire?
Our index shows an expiration date of Jul 11, 2039 (13 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.